Return to Article Details
CARDIOMETABOLIC STRATEGIES IN HEART FAILURE AND CHRONIC KIDNEY DISEASE: FROM GLP-1 RECEPTOR AGONISTS TO IMPROVED QUALITY OF LIFE AND TECHNOLOGY-ENABLED CARE
Download
Download PDF